Purchase Order 75N95024P00097
Award Date
1/19/24
Potential Completion Date
1/18/25
Potential Value
$11K
Federal Agency
National Institute on Drug Abuse
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $95,768.60 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide 12 units of its Infinium Global Diversity Array-8 v1.0 kit with 96 samples per unit and 1 unit with 48 samples to support the agency's biomedical research efforts. Performance will take place in San Diego through August 2024. No set aside...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $38,362.17 firm fixed price purchase order to Illumina, Inc. on December 14, 2018 for goods and services to be delivered by December 16, 2019. The place of performance is Bethesda, Maryland. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. No set-aside provision was used for this award to support the National...
The National Institutes of Health's National Institute on Drug Abuse awarded a $6.5 million firm fixed price delivery order to Illumina, Inc. of San Diego, California. The order is for NOVASEQ 6000 S4 reagents kits to support library preparation and whole genome sequencing as part of NIH/NIDA's ongoing biomedical research efforts. Performance will take place in San Diego through June 2021. Illumina will provide the requested next-generation sequencing products and services as the prime...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,478 purchase order to Thermo Electron North America LLC for a PCI KIT TO CONDUCT DPCR EXPERIMENTS. As the prime contractor, Thermo Electron North America LLC will deliver the requested polymerase chain reaction kit and related materials from its Baltimore, Maryland location to support drug abuse research being conducted by the National Institute on Drug Abuse. The firm fixed...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $250,675.20 award, with a completion date of March 8, 2018, is for the provision of sequencing systems, reagents, consumables, and associated services to support the agency's genomics research and diagnostics efforts. Illumina has...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and consumables. The award, valued at $12,524.80, is for the delivery of Illumina sequencing systems and related products to support NIDA's research and diagnostics needs. This award is not associated with a set-aside program. Illumina has received multiple...
The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded a $23,106.28 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for the delivery of INFINIUM Global Diversity Array 8 Version 1.0 Kits to support NIAAA's research efforts. No major subcontractors or set aside designations were identified. The location of performance will be Illumina's facilities in San Diego. The one month period of performance spans from...
This is a $23,256.80 firm fixed price delivery order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of NIAAA - INF METHYLATIONEPIC V2.0 KIT, which appears to be a genomic sequencing product. The contract has an ultimate completion date of September 2, 2025. Illumina is a manufacturer of sequencing and array-based analytical instruments and reagents that...
This firm fixed-price purchase order for $306,030.00 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Illumina, Inc. The contract is for the provision of a sequencing instrument required for high-output sequencing gene expression analysis, under the Major Program Code "SEQUENCING INSTRUMENT REQUIRED FOR HIGH-OUTPUT SEQUENCING GENE EXPRESSION ANALYSIS". The award has a completion date of December...
This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $82,507.48 contract has no set-aside designation and does not appear to be associated with a larger contracting vehicle. Under this award, Illumina will provide NIDA with various sequencing systems, reagents, consumables, and related services to support genomic research and diagnostics....